drug · small molecule
dexamethasone SR
Phase 3updated 3mo agoby $OCUL OCULAR THERAPEUTIX, INC🔗 ChEMBL
Phase 3community read0 votes
🐶 often sniffed alongside
top 8- tagApproval82 co-mentions · 21 sources
- drugOZURDEX40 co-mentions · 20 sources
- drugdexamethasone LA28 co-mentions · 14 sources
- tagOphthalmology12 co-mentions · 6 sources
- drug(dexamethasone + tobramycin)12 co-mentions · 6 sources
- tagRecall11 co-mentions · 9 sources
- drugdexamethasone sodium phosphate8 co-mentions · 3 sources
- drugdexamethasone sodium phosphate SR8 co-mentions · 3 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 75 approved and 174 investigational indications.
targets
Glucocorticoid receptor
all catalysts(0)
nothing on the calendar yet
Trials studying dexamethasone SR
- phase1A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
- phase3Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
- phase1A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma
- phase3A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- phase3Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients
- phase2Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
- phase2Comparing Lower Versus Standard Doses of Belantamab Mafodotin With Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma.
- phase4An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 51m ago
Found something off?
comments(0)
5-min edit window · permanent after that